JJSF News Alert J & J Snack Foods (JJSF) 106.11 12/13/2014 0

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2014 at 3:18 AM

J & J Snack Foods (JJSF) 106.11 $JJSF

J&J SNACK FOODS
at Investor's Business Daily - Wed Dec 10, 5:43PM CST
J&J SNACK FOODS (JJSF) announced a 12.5% hike in its quarterly cash dividend, to 36 cents per share from 32 cents, payable Jan. 8, to shareholders of record as of Dec. 24, '14. Shares fell.
JJSF: 106.11 (-2.34)

J&J Snack Foods declares $0.36 dividend
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 3:19PM CST

JJSF: 106.11 (-2.34)

J & J Snack Foods Corp. Announces Increase in Quarterly Cash Dividend
GlobeNewswire - Wed Dec 10, 3:00PM CST
J & J Snack Foods Corp. (Nasdaq:JJSF) announced today that its Board of Directors has declared a regular quarterly cash dividend of $.36 per share of its common stock payable on January 8, 2015 to shareholders of record as of the close of business on December 23, 2014. The cash dividend of $.36 per share represents an increase of 12-1/2% from the previous quarterly dividend rate of $.32 per share.
JJSF: 106.11 (-2.34)

J&J Snack Foods FY 2014 Earnings: Consumers Love Their Soft Pretzels
William Bias - at Seeking Alpha - Fri Nov 21, 3:10AM CST

JJSF: 106.11 (-2.34)

Dividend Contenders: 26 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Mon Nov 17, 6:36AM CST

RGCO: 21.50 (-0.01), ROP: 149.89 (-3.14), SEIC: 39.56 (-0.69), NKE: 96.17 (-0.76), SJI: 57.97 (-1.02), AEL: 27.73 (-0.12), YORW: 21.05 (-0.55), ECL: 102.33 (-2.31), SYK: 92.00 (-1.41), AXS: 49.24 (-0.64), TGP: 38.21 (-0.92), JJSF: 106.11 (-2.34), GGG: 77.40 (-1.54), NWFL: 29.29 (+0.29), CVS: 89.94 (-0.99), UBA: 22.08 (-0.31), ERIE: 90.79 (-1.26), ANDE: 50.47 (-1.99), EIX: 64.00 (-0.43), LG: 50.77 (-0.86), LNT: 63.40 (-0.91), VGR: 20.27 (-0.37)

How Flowers Foods is Wilting From Rising Costs and Competition
at The Street - Wed Nov 12, 5:15AM CST
With the company having missed earnings estimates in several of the previous four quarters, Flowers is struggling to thrive in front of Wall Street.
SPY: 200.89 (-3.30), JJSF: 106.11 (-2.34), CPB: 43.75 (-0.67), FLO: 18.93 (-0.24)

Update: J&J Snack Foods Fiscal 4Q Earnings Shows Pretzels Still Strong
Marshall Hargrave - at Seeking Alpha - Wed Nov 12, 2:41AM CST

JJSF: 106.11 (-2.34)

The Best Small-Cap Dividend Growers
Stan Stafford - at Seeking Alpha - Tue Nov 11, 2:32PM CST

CALM: 40.23 (-2.11), BGS: 29.58 (-1.36), JJSF: 106.11 (-2.34), SAFM: 86.33 (-4.37), LNCE: 29.43 (-0.91)

Dean Foods Gains on Narrower than Expected Q3 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:30AM CST
Shares of Dean Foods Company (DF) gained 13.7% yesterday, after the nation's largest dairy processor posted narrower-than-expected loss for third-quarter 2014.
HAIN: 110.26 (-2.76), JJSF: 106.11 (-2.34), CAG: 36.73 (-0.56), DF: 18.00 (+0.18)

Update: J&J Snack Foods Continuing To Impress Under The Radar
Jeffrey Himelson - at Seeking Alpha - Sat Nov 08, 1:58AM CST

JJSF: 106.11 (-2.34)

J&J Snack Foods' (JJSF) CEO Gerry Shreiber on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 11:49AM CST

JJSF: 106.11 (-2.34)

J&J Snack Foods posts 4Q profit
Automated Insights - Thu Nov 06, 4:48PM CST
PENNSAUKEN, N.J. (AP) _ J&J Snack Foods Corp. (JJSF) on Thursday reported profit of $22.2 million, or $1.19 per share, in its fiscal fourth quarter.
JNJ: 104.43 (-2.29), JJSF: 106.11 (-2.34)

J & J Snack Foods beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 3:05PM CST

JJSF: 106.11 (-2.34)

Sales and Earnings Reported by J & J Snack Foods
GlobeNewswire - Thu Nov 06, 3:00PM CST
J & J Snack Foods Corp. (Nasdaq:JJSF) today announced sales and earnings for its fourth quarter and year ended September 27, 2014.
JJSF: 106.11 (-2.34)

J & J Snack Foods Schedules Fourth Quarter Conference Call
GlobeNewswire - Wed Oct 29, 9:41AM CDT
J & J Snack Foods Corp. (Nasdaq:JJSF) announced today that its conference call to discuss its fourth quarter 2014 results is scheduled for Friday, November 7, 2014 at 10:00 am Eastern time.
JJSF: 106.11 (-2.34)

Dividend Contenders: 34 Increases Expected By December 31
David Fish - at Seeking Alpha - Sat Oct 18, 5:44PM CDT

CASS: 47.58 (-0.14), MATW: 45.71 (-1.04), SEIC: 39.56 (-0.69), SFG: 65.41 (-1.54), NKE: 96.17 (-0.76), NKSH: 29.99 (-0.79), MDU: 21.71 (-0.91), SJI: 57.97 (-1.02), AEL: 27.73 (-0.12), MSM: 77.69 (-1.42), UMBF: 53.16 (-0.59), AAN: 27.48 (+0.32), YORW: 21.05 (-0.55), SYK: 92.00 (-1.41), ECL: 102.33 (-2.31), AXS: 49.24 (-0.64), WHG: 59.00 (-0.34), JJSF: 106.11 (-2.34), AROW: 26.25 (-0.04), LECO: 67.57 (-1.34), BRO: 31.92 (-0.52), WABC: 46.95 (-0.63), UBA: 22.08 (-0.31), RGLD: 67.48 (-0.30), ANDE: 50.47 (-1.99), UTMD: 55.34 (-1.35), EIX: 64.00 (-0.43), LG: 50.77 (-0.86), PB: 53.33 (-0.89), VGR: 20.27 (-0.37)

Will Golden Monkey Improve Hershey Revenues, Profits? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 6:00PM CDT
The Hershey Company (HSY) completed the previously announced acquisition of 80% interest in Shanghai-based chocolate maker, Shanghai Golden Monkey.
HAIN: 110.26 (-2.76), JJSF: 106.11 (-2.34), CAG: 36.73 (-0.56), HSY: 98.52 (-1.06)

Kroger's Customer 1st Strategy Supports Consistent Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 3:20PM CDT
A dominant position among the nation's largest grocery retailers enables Kroger (KR) to expand its store base and boost its market share by introducing new products.
HAIN: 110.26 (-2.76), KR: 61.55 (-0.34), JJSF: 106.11 (-2.34), THS: 82.45 (-1.82)

Diamond Foods Up on Strong Q4 Earnings, Gives FY15 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 8:30AM CDT
Shares of Diamond Foods Inc. (DMND) gained nearly 6.5% during yesterday's after-hours trading session after the company posted strong financial results for the fourth quarter and fiscal 2014.
HAIN: 110.26 (-2.76), DMND: 28.13 (-0.44), JJSF: 106.11 (-2.34), BDBD: 10.07 (-0.21)

Flowers Foods Down to Strong Sell on Lowered 2014 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 10:40AM CDT
Zacks Investment Research downgraded Flowers Foods, Inc. (FLO) to a Zacks Rank #5 (Strong Sell) on Sep 23, 2014. Going by the Zacks model, companies holding a Zacks Rank #5 have strong chances of performing worse than the broader market.
HAIN: 110.26 (-2.76), ARMK: 28.29 (-0.27), JJSF: 106.11 (-2.34), FLO: 18.93 (-0.24)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Xiaomi's Smart Auto Factory Draws Global Media Praise

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...